137 results on '"Giusto, Michela"'
Search Results
2. What is new about diet in hepatic encephalopathy
3. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections
4. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease
5. Improvement of nutritional status in malnourished cirrhotic patients one year after liver transplantation
6. Nutritional Status and Liver Transplantation
7. An empirical broad spectrum antibiotic therapy in health-care–associated infections improves survival in patients with cirrhosis: A randomized trial
8. Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections
9. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study
10. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis
11. MuRF-1 and p-GSK3β expression in muscle atrophy of cirrhosis
12. Graft macrosteatosis and time of T-tube removal as risk factors for biliary strictures after liver transplantation
13. Ribavirin transporter gene polymorphism influences viral kinetics and represents a novel pre-treatment predictor of rapid virologic response in liver transplanted patients with hepatitis C virus recurrence: a proof of concept: 206
14. Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients
15. Anemia is not predictive of sustained virological response in liver transplant recipients with hepatitis C virus who are treated with pegylated interferon and ribavirin
16. Nutritional status: its influence on the outcome of patients undergoing liver transplantation
17. The Effect of 12 Weeks of β-Hydroxy-β-Methyl-Butyrate Supplementation after Liver Transplantation: A Pilot Randomized Controlled Study
18. Impaired Ribosomal Biogenesis by Noncanonical Degradation of β-Catenin during Hyperammonemia
19. Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort
20. Prevalent use of Combined Prophylaxis of Hepatitis B after liver transplantation in Italy: Results of a national survey in a large cohort
21. Chronic Kidney Disease After Liver Transplantation
22. An empirical broad spectrum antibiotic therapy in Healthcare-Associated infections improves survival in cirrhotics: A randomized trial
23. Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis
24. Impaired Ribosomal Biogenesis by Non-Canonical Degradation of β-catenin during Hyperammonemia.
25. Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass
26. COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN AND LAMIVUDINE IN PATIENTS TRANSPLANTED FOR HBV END STAGE LIVER DISEASE: STILL COST-EFFECTIVE?
27. POST-TRANSPLANTATION METABOLIC SYNDROME: IS IT ONLY A THERAPEUTIC CONCERN?
28. HIGH PREVALENCE OF MDR INFECTIONS IN CIRRHOTIC PATIENTS WHO HAVE HAD CONTACT WITH THE HEALTHCARE SYSTEM
29. CHANGES IN BODY COMPOSITION IN THE FIRST MONTHS AFTER LIVER TRANSPLANTATION
30. DIASTOLIC DYSFUNCTION EVALUATED WITH TISSUE DOPPLER IMAGING IN CIRRHOTIC PATIENTS IS NOT ASSOCIATED WITH A MORE SEVERE LIVER IMPAIRMENT
31. THE INCREASE IN CARDIAC OUTPUT AND STROKE VOLUME AFTER TOTAL PARACENTESIS IS SUPPORTED BY ALBUMIN ADMINISTRATION IN HYPOVOLEMIC CIRRHOTIC PATIENTS
32. PROPHYLAXIS WITH BETA-BLOCKERS AND LOWER USE OF PROTON PUMP INHIBITORS MAY REDUCE THE PREVALENCE OF INFECTIONS IN CIRRHOTIC PATIENTS
33. SEPSIS REPRESENTS A NEGATIVE PROGNOSTIC FACTOR IN SHORT AND LONG TERM IN HOSPITALIZED CIRRHOTIC PATIENTS
34. Ribavirin Transporter [Ent1] Polymorphism is a Pretreatment Predictor of Virologic Response: The Specific Role of Donor Liver Transporter
35. What is new about diet in hepatic encephalopathy
36. Bone disorders in patients with chronic liver disease awaiting liver transplantation
37. The Spread of Multi Drug Resistant Infections Is Leading to an Increase in the Empirical Antibiotic Treatment Failure in Cirrhosis: A Prospective Survey
38. Sarcopenia in liver cirrhosis
39. BACTERIAL INFECTIONS AND SEPSIS ACUTELY DETERIORATE LIVER FUNCTION IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY
40. Diet therapy in patients with liver disease and liver transplant
41. MOLECULAR REGULATION OF LIVER GRAFT CHOLESTEROL METABOLISM AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION
42. MOLECULAR STUDY OF HEPATOCELLULAR CHOLESTEROL HOMEOSTASIS IN HUMAN LIVER TRANSPLANTATION
43. Gestione domiciliare dopo trapianto di fegato
44. FACTORS INFLUENCING SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION
45. SEQUENTIAL CHANGES IN NUTRITIONAL STATUS, ENERGY EXPENDITURE, DIETARY INTAKE DURING THE FIRST SIX MONTHS AFTER LIVER TRANSPLANTATION
46. SUCCESSFUL COMBINED LONG TERM PROPHYLAXIS WITH LAMIVUDINE AND LOW DOSE HEPATITIS B IM IMMUNOGLOBULIN IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE
47. CALCINEURIN INHIBITORS REDUCTION IN LIVER TRANSPLANTED PATIENTS WITH CHRONIC RENAL DYSFUNCTION: RESULTS IN CURRENT CLINICAL PRACTICE
48. AUTOIMMUNE DE NOVO HEPATITIS FOLLOWING ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION
49. AUTOIMMUNE DE NOVO HEPATITIS IN TRANSPLANTED PATIENTS FOLLOWING ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE
50. Molecular mechanisms underlying muscle loss in cirrhotic patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.